Home › Funds › EVENTIDE ASSET MANAGEMENT, LLC › CLDX
EVENTIDE ASSET MANAGEMENT, LLC position in CLDX
CELLDEX THERAPEUTICS INC NEW · Health Care
EVENTIDE ASSET MANAGEMENT, LLC reported holding 1,896,637 shares of CLDX (CELLDEX THERAPEUTICS INC NEW) in its Q3 2026 13F filing — a position valued at US$61.5M, representing 0.86% of its reported portfolio and ranking #33 among its reported holdings. EVENTIDE ASSET MANAGEMENT, LLC has disclosed CLDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How EVENTIDE ASSET MANAGEMENT, LLC's CLDX position evolved
EVENTIDE ASSET MANAGEMENT, LLC first disclosed a stake in CLDX in Q3 2023 at 1,600,000 shares (US$44.0M). The position peaked in Q4 2023 at 3,630,013 shares, worth US$144.0M. Across 13 filings, EVENTIDE ASSET MANAGEMENT, LLC increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 1,896,637 shares valued at US$61.5M — an increase of 859,637 shares quarter over quarter.. Notable position changes include a 127% increase in Q4 2023 (shares rose 6% over the following quarter), a 64% trim in Q2 2025 (shares rose 27% over the following quarter), a 83% increase in Q3 2026 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.60M | $44.03M | New |
| Q4 2023 | 3.63M | $143.97M | Add |
| Q1 2024 | 3.12M | $130.91M | Reduce |
| Q2 2024 | 3.33M | $123.14M | Add |
| Q3 2024 | 3.33M | $113.25M | Hold |
| Q4 2024 | 3.75M | $94.84M | Add |
| Q1 2025 | 3.75M | $68.18M | Hold |
| Q2 2025 | 1.36M | $27.60M | Reduce |
| Q3 2025 | 1.86M | $48.10M | Add |
| Q4 2025 | 1.64M | $44.61M | Reduce |
| Q1 2026 | 1.04M | $32.89M | Reduce |
| Q2 2026 | 1.04M | $38.59M | Hold |
| Q3 2026 | 1.90M | $61.46M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLDX and 13F data
CLDX (CELLDEX THERAPEUTICS INC NEW) is a Health Care company. 40 other funds we track also report a position in CLDX — the largest reported positions include Kynam Capital Management, LP (US$198.1M), Deep Track Capital, LP (US$109.4M), Logos Global Management LP (US$78.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLDX
- Kynam Capital Management, LP 5.32M sh · $198.07M · Q2 2026
- Deep Track Capital, LP 2.94M sh · $109.37M · Q2 2026
- Logos Global Management LP 2.10M sh · $78.14M · Q2 2026
- Eversept Partners, LP 1.79M sh · $66.45M · Q2 2026
- Commodore Capital LP 1.35M sh · $50.23M · Q2 2026
- Bellevue Group AG 1.20M sh · $44.65M · Q2 2026
- BAKER BROS. ADVISORS LP 1.18M sh · $44.00M · Q2 2026
- Novo Holdings A/S 1.02M sh · $38.14M · Q2 2026
- Affinity Asset Advisors, LLC 1.16M sh · $37.61M · Q3 2026
- Elmind Capital, LP 990.00K sh · $36.84M · Q2 2026
- Foresite Capital Management VI LLC 879.71K sh · $32.73M · Q2 2026
- Rock Springs Capital Management LP 699.15K sh · $26.02M · Q2 2026
More on EVENTIDE ASSET MANAGEMENT, LLC
FAQ
How long has EVENTIDE ASSET MANAGEMENT, LLC held CLDX?
EVENTIDE ASSET MANAGEMENT, LLC has disclosed CLDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is EVENTIDE ASSET MANAGEMENT, LLC's current position in CLDX?
As of Q3 2026, EVENTIDE ASSET MANAGEMENT, LLC holds 1.90M shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $61.46M, representing 0.86% of its reported portfolio and ranking #33.
Has EVENTIDE ASSET MANAGEMENT, LLC been buying or selling CLDX?
In the latest 13F filing (Q3 2026), EVENTIDE ASSET MANAGEMENT, LLC increased its position in CLDX. The position peaked in Q4 2023 at 3.63M shares.
Which other funds hold CLDX?
Other major institutional holders of CLDX include Kynam Capital Management, LP, Deep Track Capital, LP, Logos Global Management LP, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.